Journal of Clinical & Experimental Pharmacology

Syreeta L Tilghman

Syreeta L Tilghman
Division of Basic Pharmaceutical Sciences
University of Louisiana, USA

Biography

Dr. Syreeta L. Tilghman earned a Bachelor of Science in Chemistry from the University of Maryland Eastern Shore. She received a Ph.D. in Pharmacology and Experimental Therapeutics from the University of Maryland, Baltimore where she was trained under Dr. Angela Brodie. Her predoctoral studies focused on demonstrating that upregulation of AIB1 amplified in breast cancer-1, aromatase and ER61537; estrogen receptor 61537; provide long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survival. Upon completion of her doctoral studies, Dr. Tilghman carried out her post-doctoral studies with Dr. Matthew E. Burow at Tulane University in the Center for Bioenvironmental Research. Here, her research centered on identifying the mechanisms by which a novel phytoantiestrogen, glyceollin, suppresses human breast tumorigenesis. Dr. Tilghman joined Xavier University College of Pharmacy as an assistant professor of Pharmacology.

Research Interest

Dr. Tilghman’s research interests involve investigating the use of novel phytochemicals in endocrine resistant breast cancers.